Professional Overview
Meet Dr. Sachita Baniya
Dr. Sachita Baniya (NMC 20158) is a Consultant Haemato-Oncologist and Clinical Hematologist practising in Nepal. She completed her MBBS at Kumudini Women's Medical College and FCPS in Clinical Haematology, followed by clinical residency at Civil Service Hospital, Kathmandu. With 8+ years of clinical experience and more than 1,000 bone marrow procedures, she evaluates and manages leukemia, lymphoma, multiple myeloma and complex haematological malignancies. Her clinical work includes autologous, allogeneic and haplo-identical bone marrow transplantation, CAR-T cell therapy, advanced molecular testing and flow cytometry. She consults at Kathmandu Neurology Clinic & Cognitive Center, Durbar Marg, and is affiliated with Kathmandu Cancer Center (KCC) Nepal, Civil Service Hospital, Kathmandu, and Advanced Care Hospital. Her approach emphasises precise diagnosis, clear discussion of treatment options, careful monitoring, and continuity of care for patients and families living with blood cancers and complex blood disorders.
Verified credentials
- NMC
- NMC 20158
- Hours
- By appointment
Verify NMC 20158 at the Nepal Medical Council registry ↗
Affiliations
- - Kathmandu Neurology Clinic & Cognitive Center, Durbar Marg — Consultant Haemato-Oncologist & Clinical Hematologist
- - Kathmandu Cancer Center (KCC) Nepal — Consultant Haemato-Oncologist & Clinical Hematologist
- - Civil Service Hospital, Kathmandu — Clinical Hematologist
- - Advanced Care Hospital — Consultant Haemato-Oncologist & Clinical Hematologist
Qualifications
All qualifications are verified and current.
- MBBS
- FCPS (Clinical Haematology)
Education and training
- MBBS — Kumudini Women's Medical College
- FCPS (Clinical Haematology)
- Clinical residency — Civil Service Hospital, Kathmandu
Specialties
Conditions Evaluated
Each with a dedicated guide where available.
Services
Haematology Consultation
Specialist assessment for abnormal blood counts, anaemia, low platelets, bleeding, clotting and suspected blood disorders.
Haemato-Oncology Consultation
Consultation for suspected or confirmed blood cancers — leukemia, lymphoma, myeloma and related disorders.
Leukemia Treatment
Diagnosis, risk stratification and treatment planning for acute and chronic leukemias.
Lymphoma Treatment
Diagnosis, staging and treatment planning for Hodgkin and non-Hodgkin lymphomas.
Multiple Myeloma Treatment
Diagnosis and treatment of multiple myeloma, MGUS, smouldering myeloma and AL amyloidosis.
Myelodysplastic Syndrome Treatment
Risk-adapted care for myelodysplastic syndromes and unexplained cytopenias.
Myeloproliferative Neoplasm Treatment
Care for polycythaemia vera, essential thrombocythaemia and primary myelofibrosis.
Bone Marrow Transplant
Autologous, allogeneic and haplo-identical transplant assessment and coordination.
Autologous Bone Marrow Transplant
High-dose therapy with the patient's own stem cells for myeloma and selected lymphomas.
Allogeneic Bone Marrow Transplant
Donor stem cell transplant for selected high-risk blood cancers and marrow failure.
Haplo-Identical Bone Marrow Transplant
Half-matched family donor transplant when a fully matched donor is unavailable.
CAR-T Cell Therapy
Eligibility assessment, referral coordination and follow-up for CAR-T cell therapy.
Bone Marrow Aspiration & Biopsy
Diagnostic bone marrow sampling for cytopenias, suspected blood cancer and treatment monitoring.
Flow Cytometry Evaluation
Immunophenotyping for leukemia, lymphoma, plasma cell disorders and cytopenias.
Molecular Testing in Haematology
Cytogenetics, FISH, PCR and next-generation sequencing for blood cancers.
Anaemia Evaluation
Structured investigation of low haemoglobin — iron deficiency, haemolysis and marrow causes.
Thrombocytopenia Evaluation
Assessment of low platelets including ITP, TTP, drug causes and marrow disorders.
Bleeding Disorder Evaluation
Diagnosis and management of haemophilia, von Willebrand disease and inherited bleeding.
Thrombosis & Anticoagulation
Assessment and management of venous thromboembolism and cancer-associated thrombosis.
Transfusion Support
Red cell and platelet transfusion support for haematological disease and treatment.
Chemotherapy Supportive Care
Infection prevention, transfusion, nausea control and monitoring during blood cancer treatment.
Neutropenia Evaluation
Investigation and management of low white cell counts and recurrent infection.
Graft-Versus-Host Disease Management
Recognition and management of acute and chronic GVHD after allogeneic transplant.
Blood Cancer Survivorship Care
Long-term follow-up after blood cancer treatment and transplantation.
Haematology Second Opinion
Independent review of blood cancer diagnosis, pathology and treatment plans.
Benign Haematology Evaluation
Care for anaemia, cytopenias, bleeding and clotting disorders, thalassaemia and sickle cell disease.
Consultation
Care begins with a precise diagnosis: a careful review of symptoms, blood counts, bone marrow findings, flow cytometry, cytogenetics and molecular results, followed by a clear explanation of what is known and what still needs testing. Treatment plans are individualised and discussed with benefits, limitations, supportive-care needs and follow-up. For blood cancers, the focus is on evidence-based treatment, careful infection and transfusion support, and long-term monitoring. For transplant and CAR-T candidates, eligibility, risks, expected recovery and coordination with the treating team are reviewed openly.
- Referral & Initial Consultation: Review of symptoms, blood counts, prior reports, bone marrow studies, flow cytometry and molecular results, followed by a clear plan for any additional testing.
- Diagnostic Work-up: Targeted blood tests, bone marrow aspiration or biopsy, immunophenotyping, cytogenetics and molecular testing — ordered only when they will affect diagnosis or treatment.
- Diagnosis & Staging: Integration of clinical, morphological, immunophenotypic and genetic findings to establish the diagnosis, subtype and risk profile.
- Treatment Planning: Discussion of treatment options, expected benefits, side effects, supportive care and the role of transplant or cellular therapy where relevant.
- Transplant or CAR-T Coordination: For eligible patients, review of transplant or CAR-T indications, pre-treatment work-up, coordination with the treating centre and monitoring for complications.
- Follow-up & Survivorship: Regular blood counts, disease monitoring, infection and GVHD surveillance, supportive care and long-term survivorship planning.
Authority Topics
Articles
Blood Cancer Symptoms: When to See a Haematologist
Unexplained bruising, persistent fatigue, swollen lymph nodes or repeated infections can be early signs of a blood disorder. Here is when to seek a haematology opinion.
AML Diagnosis Explained: From Blood Count to Genetic Risk
How acute myeloid leukemia is diagnosed, why bone marrow and genetic testing matter, and what the results mean for treatment.
CML and TKI Therapy: Why BCR-ABL1 Monitoring Matters
Chronic myeloid leukemia is controlled with tyrosine kinase inhibitors. Regular BCR-ABL1 monitoring tells you whether treatment is working.
Lymphoma: Symptoms, Biopsy and What Comes Next
Lymphoma often starts with a painless swollen lymph node. Learn how the diagnosis is made and why the biopsy matters.
Multiple Myeloma: A Practical Guide for Patients and Families
Myeloma is a treatable plasma cell cancer. Understand the tests, treatment options, transplant and supportive care.
MGUS: What It Means and How Often to Monitor
Monoclonal gammopathy of undetermined significance is a common precursor condition. Most people with MGUS never develop myeloma.
Frequently Asked Questions
Reviewed by Dr. Sachita Baniya (NMC 20158).
Dr. Sachita Baniya (NMC 20158) — MBBS, FCPS (Clinical Haematology), Consultant Haemato-Oncologist & Clinical Hematologist based in Kathmandu, Nepal. Practice locations: Kathmandu Neurology Clinic & Cognitive Center, Durbar Marg (Haematology and haemato-oncology consultation by appointment); Kathmandu Cancer Center (KCC) Nepal (Haemato-oncology, bone marrow transplant and CAR-T services); Civil Service Hospital, Kathmandu (Clinical haematology and bone marrow procedures); Advanced Care Hospital (Haematology and haemato-oncology consultation).
Clinical Haematology, Haemato-Oncology, Leukemia, Lymphoma, Multiple Myeloma, Complex Haematological Malignancies, Bone Marrow Transplantation, Autologous Bone Marrow Transplant — with dedicated expertise in Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myeloid Leukemia (CML), Chronic Lymphocytic Leukemia (CLL), Leukemia with complex cytogenetics.
Kathmandu Neurology Clinic & Cognitive Center, Durbar Marg (Haematology and haemato-oncology consultation by appointment); Kathmandu Cancer Center (KCC) Nepal (Haemato-oncology, bone marrow transplant and CAR-T services); Civil Service Hospital, Kathmandu (Clinical haematology and bone marrow procedures); Advanced Care Hospital (Haematology and haemato-oncology consultation)
Bring prior imaging and lab reports, current medication list, allergy history, symptom diary if applicable, and notes on onset and triggers.
Care begins with a precise diagnosis: a careful review of symptoms, blood counts, bone marrow findings, flow cytometry, cytogenetics and molecular results, followed by a clear explanation of what is known and what still needs testing. Treatment plans are individualised and discussed with benefits, limitations, supportive-care needs and follow-up. For blood cancers, the focus is on evidence-based treatment, careful infection and transfusion support, and long-term monitoring. For transplant and CAR-T candidates, eligibility, risks, expected recovery and coordination with the treating team are reviewed openly.
A haemato-oncologist diagnoses and treats blood cancers and complex blood disorders — leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, myeloproliferative neoplasms and related conditions. Dr. Sachita Baniya (NMC 20158) also manages benign haematology such as anaemia, low platelets, bleeding and clotting disorders, and oversees bone marrow transplantation and CAR-T follow-up.
Consider a haematology opinion for persistent abnormal blood counts, unexplained anaemia, low platelets or white cells, enlarged lymph nodes, unexplained bruising or bleeding, a suspected blood cancer, or when a bone marrow, flow cytometry or molecular report needs interpretation. A referral is helpful but not always required.
A bone marrow test samples the liquid and solid parts of the marrow, usually from the back of the hip bone, under local anaesthetic. It helps diagnose leukemia, lymphoma, myeloma, myelodysplasia and bone marrow failure, and is used to monitor response after treatment. Dr. Baniya has performed more than 1,000 bone marrow procedures.
Autologous transplant uses the patient's own stem cells after high-dose treatment. Allogeneic transplant uses cells from a matched donor, usually a sibling or unrelated volunteer. Haplo-identical transplant uses a half-matched donor, often a parent or child. The choice depends on the disease, its risk, the patient's fitness and donor availability.
CAR-T is a cellular therapy in which a patient's T cells are engineered to recognise a specific marker on cancer cells, then returned after conditioning treatment. It is used in selected relapsed or refractory blood cancers. Dr. Baniya assesses eligibility, coordinates referral, and monitors for cytokine release syndrome, neurological toxicity and infection after infusion.
Diagnosis combines clinical assessment, blood counts, peripheral smear, bone marrow aspiration and biopsy, flow cytometric immunophenotyping, cytogenetics, FISH and molecular testing. Lymphoma usually requires a lymph node biopsy. The results together establish the subtype, risk profile and appropriate treatment.
MRD refers to small numbers of cancer cells that remain after treatment but are below the limit of routine microscopy. It is measured with flow cytometry or molecular methods and helps judge depth of response, compare treatment options and detect early relapse in conditions such as leukemia and myeloma.
Yes. Multiple myeloma is a treatable, often chronic cancer. Treatment may include combination therapy, targeted agents, autologous transplant in eligible patients and supportive care for bone disease, infection and kidney involvement. Response is monitored with protein studies, bone marrow assessment and MRD testing where available.
Supportive care includes transfusion support, infection prevention and treatment, growth factors where indicated, nausea and pain control, nutrition and hydration, and monitoring of organ function. Patients are educated on fever, bleeding and other warning signs that need urgent review.
GVHD occurs when donor immune cells attack the recipient's tissues after an allogeneic transplant, most commonly affecting skin, gut and liver. It can be acute or chronic. Prevention and early treatment are part of transplant follow-up, along with infection surveillance and medication monitoring.
A second opinion can be valuable when the diagnosis is complex, the treatment options are closely balanced, or a transplant or CAR-T decision is being considered. Review of the bone marrow, flow cytometry, cytogenetics and molecular reports is often the most useful starting point.
Dr. Baniya consults at Kathmandu Neurology Clinic & Cognitive Center, Durbar Marg, and is affiliated with Kathmandu Cancer Center (KCC) Nepal, Civil Service Hospital, Kathmandu, and Advanced Care Hospital. Appointments are by arrangement at the Durbar Marg clinic or through the respective hospital or cancer centre.
She provides English-language haematology consultations, second opinions on blood cancer diagnosis and treatment plans, review of bone marrow, flow cytometry and molecular reports, and transplant or CAR-T eligibility discussion. Coordination with the patient's local treating team can be arranged.
Medical Disclaimer
Content on this website is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified healthcare professional. Always seek the advice of your physician or other qualified provider with any questions regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this website. In case of a medical emergency, contact emergency services immediately. No doctor–patient relationship is established by use of this site or by contacting the clinic through the site.